DK0827503T3 - Pyrrolidinylmethylindol-salt - Google Patents

Pyrrolidinylmethylindol-salt

Info

Publication number
DK0827503T3
DK0827503T3 DK96912013T DK96912013T DK0827503T3 DK 0827503 T3 DK0827503 T3 DK 0827503T3 DK 96912013 T DK96912013 T DK 96912013T DK 96912013 T DK96912013 T DK 96912013T DK 0827503 T3 DK0827503 T3 DK 0827503T3
Authority
DK
Denmark
Prior art keywords
pyrrolidinylmethylindol
salt
pyrrolidinylmethylindol salt
Prior art date
Application number
DK96912013T
Other languages
Danish (da)
English (en)
Inventor
Martin James Wythes
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Application granted granted Critical
Publication of DK0827503T3 publication Critical patent/DK0827503T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK96912013T 1995-05-20 1996-04-10 Pyrrolidinylmethylindol-salt DK0827503T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9510223.2A GB9510223D0 (en) 1995-05-20 1995-05-20 Therapeutic agent
PCT/EP1996/001560 WO1996036632A1 (en) 1995-05-20 1996-04-10 Pyrrolidinyl methyl indole salt

Publications (1)

Publication Number Publication Date
DK0827503T3 true DK0827503T3 (da) 2000-11-20

Family

ID=10774766

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96912013T DK0827503T3 (da) 1995-05-20 1996-04-10 Pyrrolidinylmethylindol-salt

Country Status (42)

Country Link
US (1) US5994387A (is)
EP (1) EP0827503B1 (is)
JP (1) JP3233940B2 (is)
KR (1) KR100295255B1 (is)
CN (1) CN1063175C (is)
AP (1) AP738A (is)
AR (1) AR003949A1 (is)
AT (1) ATE194986T1 (is)
AU (1) AU701154B2 (is)
BG (1) BG63046B1 (is)
BR (1) BR9610858A (is)
CA (1) CA2219631C (is)
CO (1) CO5040221A1 (is)
CZ (1) CZ287939B6 (is)
DE (1) DE69609504T2 (is)
DK (1) DK0827503T3 (is)
DZ (1) DZ2034A1 (is)
ES (1) ES2148753T3 (is)
GB (1) GB9510223D0 (is)
GR (1) GR3034290T3 (is)
HK (1) HK1017884A1 (is)
HR (1) HRP960223B1 (is)
HU (1) HU217657B (is)
IL (1) IL118239A (is)
IS (1) IS1908B (is)
LV (1) LV11992B (is)
MA (1) MA23876A1 (is)
MX (1) MX9708966A (is)
MY (1) MY132066A (is)
NO (1) NO312068B1 (is)
NZ (1) NZ306448A (is)
OA (1) OA10747A (is)
PL (1) PL183142B1 (is)
PT (1) PT827503E (is)
RU (1) RU2161618C2 (is)
SK (1) SK281782B6 (is)
TN (1) TNSN96074A1 (is)
TR (1) TR199701397T1 (is)
UA (1) UA44320C2 (is)
WO (1) WO1996036632A1 (is)
YU (1) YU29496A (is)
ZA (1) ZA963938B (is)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
US20100266638A1 (en) * 2004-02-26 2010-10-21 Allergan, Inc. Headache treatment method
WO2014012859A1 (en) * 2012-07-19 2014-01-23 Boehringer Ingelheim International Gmbh Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy- chinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, its use as medicament and the preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906406C1 (is) * 1989-03-01 1990-10-25 Goedecke Ag, 1000 Berlin, De
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
AU651637B2 (en) * 1990-10-15 1994-07-28 Pfizer Inc. Indole derivatives
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.

Also Published As

Publication number Publication date
CZ364897A3 (cs) 1998-11-11
MA23876A1 (fr) 1996-12-31
HRP960223B1 (en) 2000-12-31
AU701154B2 (en) 1999-01-21
ES2148753T3 (es) 2000-10-16
KR100295255B1 (ko) 2001-08-07
AU5500596A (en) 1996-11-29
TR199701397T1 (xx) 1998-03-21
HUP9801761A2 (hu) 1999-05-28
JPH10506639A (ja) 1998-06-30
PL183142B1 (pl) 2002-05-31
CZ287939B6 (cs) 2001-03-14
PL323143A1 (en) 1998-03-16
CA2219631A1 (en) 1996-11-21
LV11992B (en) 1998-06-20
IS1908B (is) 2003-12-31
GR3034290T3 (en) 2000-12-29
UA44320C2 (uk) 2002-02-15
OA10747A (en) 2002-12-11
HK1017884A1 (en) 1999-12-03
RU2161618C2 (ru) 2001-01-10
US5994387A (en) 1999-11-30
WO1996036632A1 (en) 1996-11-21
EP0827503B1 (en) 2000-07-26
CN1185152A (zh) 1998-06-17
CO5040221A1 (es) 2001-05-29
NO312068B1 (no) 2002-03-11
ZA963938B (en) 1997-11-17
IL118239A0 (en) 1996-09-12
ATE194986T1 (de) 2000-08-15
JP3233940B2 (ja) 2001-12-04
BR9610858A (pt) 1999-07-13
BG63046B1 (bg) 2001-02-28
KR19990014934A (ko) 1999-02-25
HRP960223A2 (en) 1997-10-31
NO975210D0 (no) 1997-11-13
YU29496A (sh) 1998-12-23
TNSN96074A1 (fr) 2005-03-15
IS4605A (is) 1997-10-30
AR003949A1 (es) 1998-09-30
DE69609504D1 (de) 2000-08-31
SK281782B6 (sk) 2001-07-10
IL118239A (en) 2000-10-31
AP9600801A0 (en) 1996-04-30
MY132066A (en) 2007-09-28
EP0827503A1 (en) 1998-03-11
GB9510223D0 (en) 1995-07-19
BG102053A (en) 1998-06-30
NZ306448A (en) 1998-10-28
HUP9801761A3 (en) 1999-06-28
HU217657B (hu) 2000-03-28
SK154197A3 (en) 1999-01-11
CA2219631C (en) 2001-01-23
DE69609504T2 (de) 2000-12-14
CN1063175C (zh) 2001-03-14
MX9708966A (es) 1998-03-31
PT827503E (pt) 2000-11-30
LV11992A (lv) 1998-03-20
AP738A (en) 1999-03-23
NO975210L (no) 1997-11-13
DZ2034A1 (fr) 2002-07-21

Similar Documents

Publication Publication Date Title
DE59609887D1 (de) Substituierte cyanophenyluracile
ATA135896A (de) Skibob
DE59610332D1 (de) Substituierte aminouracile
BR9608890A (pt) N-metilenotiouréias substituídas
BR9609319A (pt) Carbonilaminofeniluracilas substituídas
ATE198470T1 (de) Alkenyl-benzoylguanidine
BR9603376A (pt) Tetrahidro-5-nitro-pirimidinas substituídas
DK0827503T3 (da) Pyrrolidinylmethylindol-salt
DE59607732D1 (de) Substituierte benzylidencyanessigester
DE59607958D1 (de) Substituierte phenyluracile
ATE240972T1 (de) Cyclopeptolide
ATA119896A (de) Scheibenmähwerk
DE29507618U1 (de) Salzstreuer
KR970000122U (ko) 소금볶음로
FI954223A (fi) Sähk¦staattisesti kontrolloitu kappale
KR960033257U (ko) 소금 볶는 장치
DE29516272U1 (de) Florleger II
BR7500809U (pt) Tele-negocios
BR7501437U (pt) Leiteira
BR7500437U (pt) Girolight
BR7500703U (pt) Rodopratic
BR7500040U (pt) Raquet mastit
BR7500825U (pt) Chutegol
BR7500838U (pt) Vassourágua
BR7500991U (pt) Caríndio